Sexually-transmitted disease (STD) markers in multitransfused children in relation to human immunodeficiency virus type-1 (HIV-1) infection: Impact of STD markers in blood donors

被引:8
作者
Chattopadhya, D
Aggarwal, R
Prakash, C
Sen, S
Kumari, S
机构
[1] NATL INST COMMUNICABLE DIS,HEPATATIS LAB,DELHI 110054,INDIA
[2] CHARAK PALIKA HOSP,DEPT PEDIAT,DELHI 110021,INDIA
关键词
D O I
10.1093/tropej/43.3.178
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Association of serological markers for various sexually transmitted diseases (STDs) with Human Immunodeficiency Virus type 1 (HIV-1) infection among heterosexually promiscuous blood donors is well recognized. However, possibility of similar association among children receiving transfusion from these donors has not been adequately explored. Study on the association of some STD markers with HIV-1 infection in multitransfused (MT) children showed that both HIV-1 positive and HIV-1 negative groups of children had significantly higher prevalence of hepatitis B virus (HBV) markers, i.e. HBsAg (23 and 30 per cent), anti-HBs (46 and 57 per cent), anti-HBc (18 and 23 per cent), antibodies to cytomegalovirus of IgM class (36 and 37 per cent) and IgG class (72.7 and 70 per cent), IgG antibodies to Herpes Simplex Virus type-2 (23 and 23 per cent) compared to control group. However, seropositivity for HIV-1 infection could not be attributed as a risk factor for any of these markers in the group of MT children. On the contrary, significant association of anti HBc, anti HCV, CMV IgG and antitreponemal antibody with HIV-1 infection could be recorded in the group of blood donors. It appeared that due to low prevalence of HIV-1 infection among blood donors in India, both HIV-1 positive and HIV-1 negative groups of MT children received transfusion from HIV negative donors predominately resulting in a comparable prevalence of STD markers in both the groups of MT children due to cumulative effect of transfusion from HIV-1 negative donors.
引用
收藏
页码:178 / 181
页数:4
相关论文
共 18 条
[1]  
ALLAIN JP, 1985, BLOOD, V66, P896
[2]  
ALTER MJ, 1989, JAMA-J AM MED ASSOC, V262, P120
[3]  
Armitage P., 2001, STAT METHODS MED RES, V4th
[4]   POLYMERASE CHAIN-REACTION FOR DETECTION OF HUMAN CYTOMEGALOVIRUS-INFECTION IN A BLOOD-DONOR POPULATION [J].
BEVAN, IS ;
DAW, RA ;
DAY, PJR ;
ALA, FA ;
WALKER, MR .
BRITISH JOURNAL OF HAEMATOLOGY, 1991, 78 (01) :94-99
[5]   THE RISK FOR HEPATITIS-A, HEPATITIS-B, AND HEPATITIS-C AT 2 INSTITUTIONS FOR CHILDREN IN SOMALIA WITH DIFFERENT SOCIOECONOMIC CONDITIONS [J].
BILE, K ;
MOHAMUD, O ;
ADEN, C ;
ISSE, A ;
NORDER, H ;
NILSSON, L ;
MAGNIUS, L .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1992, 47 (03) :357-364
[6]  
CHATTOPADHYA D, 1991, B WORLD HEALTH ORGAN, V69, P319
[7]  
DEVILLIERS FPR, 1992, S AFR MED J, V81, P84
[8]  
*NAT AIDS CONTR OR, 1994, UPD NAT AIDS CONTR P
[9]   SEROLOGIC STUDY OF CYTOMEGALOVIRUS INFECTIONS ASSOCIATED WITH BLOOD TRANSFUSIONS [J].
PRINCE, AM ;
SZMUNESS, W ;
MILLIAN, SJ ;
DAVID, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1971, 284 (20) :1125-&
[10]  
RAINA S, 1991, BRIT J OBSTET GYNAEC, V98, P141